...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
【24h】

Complementary and alternative medicine use among newly diagnosed prostate cancer patients.

机译:在新诊断的前列腺癌患者中补充和替代药物的使用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We surveyed prostate cancer patients about complementary and alternative medicine (CAM) use and evaluated patient factors that correlated with CAM use 6 months following diagnosis. METHODS: The Prostate CAncer Therapy Selection study was a prospective, observational multi-site study of men's treatment decision-making process after a diagnosis of local stage prostate cancer. Recruitment occurred in community urology practices in Washington State, hospital-based urology clinics affiliated with the University of Southern California, and Kaiser Permanente in Northern California. Eligible study participants included men over age 21 diagnosed with local stage prostate cancer between May 1, 2005 and December 31, 2006. RESULTS: Fifty-two percent of survey respondents (379) reported using one or more types of CAM. Of the patients, 51% used one CAM method, 26% used two methods, and 23% used three or more methods. The most commonly reported category was mind-body therapies (65%). Only 43% of patients discussed their CAM use with a health professional; of those, 20% informed their primary care physician and 30% told the doctor managing their prostate cancer care. Less than half thought the CAM they used was "very helpful", but a majority thought it was somewhat helpful for their condition. CONCLUSIONS: Further research is needed to characterize the goals prostate cancer patients have for CAM, whether the treatments met those goals, and how this translates into the perceived helpfulness of these therapies. The implications of patients not discussing CAM use with health professionals at the time of prostate cancer treatment need further studies.
机译:目的:我们调查了前列腺癌患者补充和替代药物(CAM)的使用情况,并评估了诊断后6个月与CAM使用相关的患者因素。方法:前列腺癌治疗选择研究是对男性阶段性前列腺癌诊断后的治疗决策过程进行的前瞻性,观察性多站点研究。华盛顿州的社区泌尿科实习,南加州大学附属的医院泌尿科诊所和北加州的Kaiser Permanente进行了招募。符合条件的研究参与者包括2005年5月1日至2006年12月31日期间被诊断患有局部前列腺癌的21岁以上男性。结果:52%的调查受访者(379)报告使用一种或多种CAM。在这些患者中,有51%使用一种CAM方法,有26%使用两种方法,而23%使用三种或更多种方法。最常报告的类别是身心疗法(65%)。只有43%的患者与医疗专业人员讨论了他们的CAM使用情况;其中,有20%的人通知了他们的初级保健医生,有30%的人告诉了管理前列腺癌治疗的医生。不到一半的人认为他们使用的CAM“非常有帮助”,但大多数人认为这对他们的病情有所帮助。结论:需要进一步研究以表征前列腺癌患者对CAM的目标,治疗是否达到这些目标以及如何将其转化为这些疗法的感知帮助。在前列腺癌治疗时未与健康专业人员讨论CAM使用的患者的含义需要进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号